Skip to main content

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis

Active, not recruiting · Phase 2 · NCT06136741

Conditions: Moderate to Severe Atopic Dermatitis

At a glance

Research payments reported, 2025
$1.1M
U.S. investigators named
28
Sites paid
27
Planned or actual enrollment
396

About the trial

Sponsor
Nektar Therapeutics
Tested
Rezpegaldesleukin (drug), Placebo (drug)
Dates
Started 2023-11-15; completion 2026-12-31
Results posted
Not yet

This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-human interleukin-2 (rezpegaldesleukin) in adult participants with moderate to severe atopic dermatitis. The estimated duration is 15-35 days for screening, an Induction Period of 16 weeks, a Maintenance Period from Week 16-Week 52, and a Posttreatment Follow-Up Period for an additional year up to approximately Week 104 for all patients. Patients with a response at Week 16 (end of induction therapy) will be re-randomized for the maintenance therapy period.

From ClinicalTrials.gov, last updated 2026-08-21. Full record, eligibility and contacts (opens in a new tab)

Industry funding

E.r. Squibb & Sons, L.l.c. reported $1.1M in research payments for this study in 2025 (29 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Sadick Dermatology Research Group $181,999
  • Apex Clinical Research Center $130,278
  • Encore Medical Research, Llc $92,945
  • Onyx Clinical Research $82,002
  • Well Pharma Med Research Corporation $65,167
  • First Oc Dermatology $55,752
  • Academic Alliance in Dermatology $50,006
  • Global Clinical Professionals Research $45,685
  • San Marcus Research Clinic, Inc $42,131
  • Cypress Dermatology $39,496
  • Premier Clinical Research $37,040
  • Wright State Physicians, Inc $30,525
  • La Universal Research Center $30,078
  • University of Texas Health Science Center at Houston $27,845
  • Dermatology Specialists Research $27,744
  • Revival Research Institute, Inc $26,420
  • 3sync Llc $22,235
  • $20,768
  • International Clinical Research $20,045
  • Dermatoogy Trial Associates $19,655
  • Clinical Science Institute $17,389
  • Dermatology Specialists of Spokane $15,812
  • Jubilee Clinical Research, Inc $10,943
  • Great Lakes Research Group $8,751
  • Velocity Clinical Research $7,003
  • Tulane University Health Sciences Center $4,250
  • Innovate Research Llc $1,750
  • North Texas Center for Clinical Research $330

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.